Insulet Cash on Hand 2010-2024 | PODD

Insulet cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Insulet cash on hand for the quarter ending September 30, 2024 was $0.903B, a 31.69% increase year-over-year.
  • Insulet cash on hand for 2023 was $0.704B, a 4.37% increase from 2022.
  • Insulet cash on hand for 2022 was $0.675B, a 14.77% decline from 2021.
  • Insulet cash on hand for 2021 was $0.792B, a 16.46% decline from 2020.
Insulet Annual Cash on Hand
(Millions of US $)
2023 $704
2022 $675
2021 $792
2020 $948
2019 $376
2018 $289
2017 $440
2016 $299
2015 $123
2014 $151
2013 $150
2012 $57
2011 $94
2010 $113
2009 $128
Insulet Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $903
2024-06-30 $821
2024-03-31 $751
2023-12-31 $704
2023-09-30 $685
2023-06-30 $660
2023-03-31 $621
2022-12-31 $675
2022-09-30 $722
2022-06-30 $709
2022-03-31 $710
2021-12-31 $792
2021-09-30 $857
2021-06-30 $872
2021-03-31 $850
2020-12-31 $948
2020-09-30 $897
2020-06-30 $844
2020-03-31 $322
2019-12-31 $376
2019-09-30 $606
2019-06-30 $310
2019-03-31 $316
2018-12-31 $289
2018-09-30 $290
2018-06-30 $300
2018-03-31 $352
2017-12-31 $440
2017-09-30 $276
2017-06-30 $259
2017-03-31 $254
2016-12-31 $299
2016-09-30 $283
2016-06-30 $111
2016-03-31 $112
2015-12-31 $123
2015-09-30 $145
2015-06-30 $145
2015-03-31 $146
2014-12-31 $151
2014-09-30 $146
2014-06-30 $176
2014-03-31 $146
2013-12-31 $150
2013-09-30 $154
2013-06-30 $151
2013-03-31 $148
2012-12-31 $57
2012-09-30 $63
2012-06-30 $70
2012-03-31 $83
2011-12-31 $94
2011-09-30 $104
2011-06-30 $107
2011-03-31 $104
2010-12-31 $113
2010-09-30 $104
2010-06-30 $118
2010-03-31 $118
2009-12-31 $128
2009-09-30 $73
2009-06-30 $52
2009-03-31 $68
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.222B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.977B 28.52
Boston Scientific (BSX) United States $155.488B 41.98
Stryker (SYK) United States $147.446B 31.70
EssilorLuxottica (ESLOY) France $140.780B 0.00
Medtronic (MDT) Ireland $112.764B 16.47
Lonza Group Ag (LZAGY) Switzerland $47.084B 0.00
Haleon (HLN) United Kingdom $44.818B 29.12
GE HealthCare Technologies (GEHC) United States $42.113B 20.51
Agilent Technologies (A) United States $39.025B 25.86
ResMed (RMD) United States $34.189B 26.33
Terumo (TRUMY) Japan $26.310B 37.41
Koninklijke Philips (PHG) Netherlands $23.527B 16.80
Zimmer Biomet Holdings (ZBH) United States $20.630B 12.95
Baxter (BAX) United States $17.074B 12.34
Sunny Optical Technology (SNPTF) China $11.331B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $11.245B 0.00
BellRing Brands (BRBR) United States $9.513B 35.65
Bio-Rad Laboratories (BIO) United States $8.001B 27.70
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $5.621B 13.06
Prestige Consumer Healthcare (PBH) United States $4.200B 20.05
ICU Medical (ICUI) United States $3.995B 38.03
Envista Holdings (NVST) United States $3.693B 29.38
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.188B 15.00
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.921B 19.69
QuidelOrtho (QDEL) United States $2.760B 23.18
LeMaitre Vascular (LMAT) United States $2.269B 55.15
Neogen (NEOG) United States $2.178B 25.10
AtriCure (ATRC) United States $1.914B 0.00
Green Thumb Industries (GTBIF) United States $1.484B 25.90
InMode (INMD) Israel $1.320B 11.03
BioLife Solutions (BLFS) United States $1.276B 0.00
AdaptHealth (AHCO) United States $1.180B 8.43
Maravai LifeSciences Holdings (MRVI) United States $0.997B 0.00
Curaleaf Holdings (CURLF) Canada $0.938B 0.00
Phibro Animal Health (PAHC) United States $0.930B 14.27
Evolus (EOLS) United States $0.926B 0.00
CeriBell (CBLL) United States $0.828B 0.00
Capricor Therapeutics (CAPR) United States $0.689B 0.00
Valneva SE (VALN) France $0.643B 0.00
Omeros (OMER) United States $0.557B 0.00
VAREX IMAGING (VREX) United States $0.529B 22.95
Owens & Minor (OMI) United States $0.494B 3.86
Surmodics (SRDX) United States $0.492B 0.00
SNDL (SNDL) Canada $0.462B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.373B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Cerus (CERS) United States $0.323B 0.00
Aurora Cannabis (ACB) Canada $0.321B 58.60
Viemed Healthcare (VMD) United States $0.310B 29.52
Sanara MedTech (SMTI) United States $0.309B 0.00
Quanterix (QTRX) United States $0.292B 0.00
OraSure Technologies (OSUR) United States $0.289B 19.40
Biote (BTMD) United States $0.260B 5.69
Canopy Growth (CGC) Canada $0.250B 0.00
Zynex (ZYXI) United States $0.236B 49.40
Sanuwave Health (SNWV) United States $0.231B 3.24
Brainsway (BWAY) Israel $0.212B 112.80
High Tide (HITI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.206B 15.39
MacroGenics (MGNX) United States $0.181B 0.00
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Organigram Holdings (OGI) Canada $0.163B 0.00
TerrAscend (TSNDF) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.140B 17.51
Jin Medical (ZJYL) China $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.112B 0.00
Fonar (FONR) United States $0.091B 12.79
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.086B 0.00
InterCure (INCR) Israel $0.075B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Exagen (XGN) United States $0.067B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Rockwell Medical (RMTI) United States $0.058B 30.00
Apyx Medical (APYX) United States $0.055B 0.00
Hongchang (HCIL) China $0.051B 0.00
MariMed (MRMD) United States $0.050B 0.00
United-Guardian (UG) United States $0.050B 14.22
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.044B 0.00
INLIF (INLF) $0.040B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00